Machine learning for functional protein design

P Notin, N Rollins, Y Gal, C Sander, D Marks - Nature biotechnology, 2024 - nature.com
Recent breakthroughs in AI coupled with the rapid accumulation of protein sequence and
structure data have radically transformed computational protein design. New methods …

Adaptive immune receptor repertoire analysis

V Mhanna, H Bashour, K Lê Quý, P Barennes… - Nature Reviews …, 2024 - nature.com
B cell and T cell receptor repertoires compose the adaptive immune receptor repertoire
(AIRR) of an individual. The AIRR is a unique collection of antigen-specific receptors that …

MBE: model-based enrichment estimation and prediction for differential sequencing data

A Busia, J Listgarten - Genome Biology, 2023 - Springer
Characterizing differences in sequences between two conditions, such as with and without
drug exposure, using high-throughput sequencing data is a prevalent problem involving …

Investigating the volume and diversity of data needed for generalizable antibody-antigen∆∆ G prediction

AM Hummer, C Schneider, L Chinery, CM Deane - bioRxiv, 2023 - biorxiv.org
Antibody-antigen binding affinity lies at the heart of therapeutic antibody development:
efficacy is guided by specific binding and control of affinity. Here we present Graphinity, an …

[HTML][HTML] Accelerating therapeutic protein design with computational approaches toward the clinical stage

Z Chen, X Wang, X Chen, J Huang, C Wang… - Computational and …, 2023 - Elsevier
Therapeutic protein, represented by antibodies, is of increasing interest in human medicine.
However, clinical translation of therapeutic protein is still largely hindered by different …

Biochemical and biophysical characterization of natural polyreactivity in antibodies

MT Borowska, CT Boughter, JJ Bunker, JJ Guthmiller… - Cell reports, 2023 - cell.com
To become specialized binders, antibodies undergo a process called affinity maturation to
maximize their binding affinity. Despite this process, some antibodies retain low-affinity …

Reduction of monoclonal antibody viscosity using interpretable machine learning

EK Makowski, HT Chen, T Wang, L Wu, J Huang… - Mabs, 2024 - Taylor & Francis
Early identification of antibody candidates with drug-like properties is essential for
simplifying the development of safe and effective antibody therapeutics. For subcutaneous …

Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability

H Bashour, E Smorodina, M Pariset, J Zhong… - Communications …, 2024 - nature.com
Designing effective monoclonal antibody (mAb) therapeutics faces a multi-parameter
optimization challenge known as “developability”, which reflects an antibody's ability to …

Prediction of polyreactive and nonspecific single-chain fragment variables through structural biochemical features and protein language-based descriptors

H Lim, KT No - BMC bioinformatics, 2022 - Springer
Background Monoclonal antibodies (mAbs) have been used as therapeutic agents, which
must overcome many developability issues after the discovery from in vitro display libraries …

Developability considerations for bispecific and multispecific antibodies

A Amash, G Volkers, P Farber, D Griffin, KS Davison… - Mabs, 2024 - Taylor & Francis
Bispecific antibodies (bsAb) and multispecific antibodies (msAb) encompass a diverse
variety of formats that can concurrently bind multiple epitopes, unlocking mechanisms to …